The approval of Covaxin for emergency use is a giant leap for
innovation and novel product development in India, Krishna Ella,
Chairman and Managing Director of the Hyderabad-based pharmaceutical
firm said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/a-great-milestone-in-indias-scientific-capability-bharat-biotech-on-approval-for-emergency-use-of-covaxin/articleshow/80082462.cms
No comments:
Post a Comment